Integrative Approaches for Cancer Survivorship

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this study is to determine whether a four-month manualized Ayurvedic intervention will improve quality of life in recent breast cancer survivors.

Key facts

Study ID

NCT01488123

Run by

University of California, San Francisco

People needed

32

Starts

2012-01-01

Expected to finish

2015-10-01

Last updated by the study team

2016-10-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female breast cancer survivor who is over 1 month and less than 12 months beyond the completion of primary therapy (surgery, radiation, and chemotherapy)
• Having received chemotherapy as part of their primary therapy for breast cancer
• Be in a complete remission
• Aged 18 years or older
• Able to read, write, and understand English
• Karnofsky Performance Status (KPS) 67 greater than 60.
• Ability to give informed consent

You may not qualify if…

• Having received Ayurvedic treatment within 2 months of study enrollment
• Receiving chemotherapy or radiotherapy at the time of study enrollment. Trastuzumab therapy is not exclusionary.
• Being within 1 month (before or after) of surgery for breast cancer (including breast reconstructive surgery). Smaller surgical procedures such as implant exchange are not exclusionary.
• Patients on adjuvant hormone therapy for less than 1 month

Where it is running

• University of California, San Francisco, Osher Center for Integrative Medicine — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.